LGDN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ligand Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 188 EUR -4.08% Market Closed

Market Cap: €3.4B

L	Ligand Pharmaceuticals Inc SWB:LGDN	US
	Valtecne SpA F:71W	IT
	Deutsche Boerse AG MIL:DB1	DE
S	Swatch Group AG SWB:UHR	CH
	ING Groep NV MIL:1INGA	NL
	Shanghai Industrial Holdings Ltd HKEX:363	HK
E	E ON SE BET:EON	DE
I	Intesa Sanpaolo SpA XHAM:IES	IT
	Twilio Inc LSE:0LHL	US
	Great Elm Capital Corp NASDAQ:GECC	US
	Lennar Corp F:LNN0	US
P	Pacific Biosciences of California Inc SWB:P09	US

Profitability Summary

Ligand Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

90%

Gross Margin is Increasing

74% > 95%

Healthy Operating Margin

18%

Low 3Y Average Operating Margin

Declining Operating Margin

23% > 18%

Exceptional Net Margin

46%

Sustainable 3Y Average Net Margin

15%

Net Margin is Increasing

17% > 46%

Exceptional Free Cash Flow Margin

18%

Strong 3Y Average Free Cash Flow Margin

22%

Declining Free Cash Flow Margin

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.